Bionano Genomics Announces Pricing Of Initial Public Offering

By Bio-IT World Staff

August 21, 2018 | Bionano Genomics today announced the pricing of its initial public offering of 3,360,000 units at a public offering price of $6.125 per unit for aggregate gross proceeds of $20,580,000, before deducting the underwriting discounts and commissions and offering expenses.

Bionano Genomics has a platform for ultra-sensitive and ultra-specific structural variation detection in genome analysis called Saphyr.

Each unit listed in the IPO consists of one share of common stock and a five-year warrant to purchase one share of common stock at an initial exercise price of $6.125 per share. In addition, Bionano has granted the underwriters a 30-day option to purchase up to 504,000 additional units at the initial public offering price, less underwriting discounts and commissions.

The units are scheduled to begin trading on The Nasdaq Capital Market under the ticker symbol “BNGOU” today, and the offering is expected to close on August 23, 2018, subject to customary closing conditions.